Literature DB >> 574156

Amantadine antagonism of oxotremorine effects.

Y Eshel, A D Korczyn.   

Abstract

Administration of oxotremorine to mice produced centrally-mediated effects, such as catalepsy and tremor, and peripheral muscarinic actions, such as diarrhoea and lachrymation. Pretreatment with amantadine (25--200 mg/kg) prevented these oxotremorine-induced effects in mice. Catalepsy was most susceptible and tremor most resistant to the administration of amantadine. The possible mechanisms involved are discussed. Our results validate the use of the oxotremorine model in the search for novel antiparkinsonian drugs.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 574156     DOI: 10.1007/bf01243431

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  11 in total

1.  Effect of amantadine on the rate of dopamine synthesis in rat corpus striatum.

Authors:  S Bariletto; E Dollar; F Leitz
Journal:  J Neurochem       Date:  1975-08       Impact factor: 5.372

2.  Anticholinergic and membrane activities of amantadine in neuromuscular transmission.

Authors:  W L Nastuk; P Su; P Doubilet
Journal:  Nature       Date:  1976-11-04       Impact factor: 49.962

3.  Antagonism by amantadine of prochlorpemazine-induced catalepsy.

Authors:  P Simon; J Malatray; J R Boissier
Journal:  J Pharm Pharmacol       Date:  1970-07       Impact factor: 3.765

4.  Anticataleptic actions of amantadine hydrochloride.

Authors:  G Zetler
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

Review 5.  L-Dopa and Parkinsonism.

Authors:  D B Calne; M Sandler
Journal:  Nature       Date:  1970-04-04       Impact factor: 49.962

6.  The effect of amantadine on motor activity and catalepsy in rats.

Authors:  J Maj; H Sowińska; L Baran
Journal:  Psychopharmacologia       Date:  1972

7.  Studies on the central effects of bulbocapnine.

Authors:  A Loizzo; A S De Carolis; V G Longo
Journal:  Psychopharmacologia       Date:  1971

8.  Abolition of oxotremorine effects by L-DOPA pretreatment.

Authors:  A D Korczyn; Y Eshel
Journal:  Neuropharmacology       Date:  1979-07       Impact factor: 5.250

9.  Studies on the mechanism of action of amantadine.

Authors:  F Brown; P H Redfern
Journal:  Br J Pharmacol       Date:  1976-12       Impact factor: 8.739

10.  The mechanism of action of amantadine in Parkinsonism: a review.

Authors:  E V Bailey; T W Stone
Journal:  Arch Int Pharmacodyn Ther       Date:  1975-08
View more
  2 in total

Review 1.  Emerging therapies in the pharmacological treatment of Parkinson's disease.

Authors:  Amos D Korczyn; Miri Nussbaum
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Drug treatment of Parkinson's disease.

Authors:  Amos D Korczyn
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.